Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Gerald Ostrov Insider Profile
4 Followers
Gerald Ostrov, Director at Oramed Pharm, holds 38.90K shares in Entera Bio (Ticker: ENTX), holds 24.90K shares in Oramed Pharm (Ticker: ORMP), holds 39.35K shares in Orasure Technologies (Ticker: OSUR).
Gerald Ostrov has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Gerald Ostrov holds in companies
Most Profitable Insider Trade
The most profitable trade made by Gerald Ostrov
Gerald Ostrov's Trading History
Oramed Pharm
Feb 25, 2015
Director
Uninformative Buy
―
$58.26K
Entera Bio
Oct 04, 2024
Director
Uninformative Buy
―
$64.96K
Orasure Technologies
May 22, 2014
Director
Uninformative Buy
―
$162.89K
List of latest transactions for each holding click on a transaction to see Gerald Ostrov's performance on stock
You May Also Like
Gerald Ostrov insider profile FAQ
What is the percentage of profitable transactions made by Gerald Ostrov?
The percentage of profitable transactions made by Gerald Ostrov is ―.
What is the average return per transaction made by Gerald Ostrov?
The average return per transaction made by Gerald Ostrov is ―.
What stocks does Gerald Ostrov hold?
Gerald Ostrov holds: ORMP, ENTX, OSUR stocks.
What was Gerald Ostrov’s latest transaction?
Gerald Ostrov latest transaction was an Uninformative Buy of ―.
What was Gerald Ostrov's most profitable transaction?
Gerald Ostrov’s most profitable transaction was an Informative Buy of ENTX stock on January 25, 2022. The return on the trade was -58.30%.
What is Gerald Ostrov's role in Oramed Pharm?
Gerald Ostrov's role in Oramed Pharm is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.